Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne M Clark

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Expert Opinion on Pharmacotherapy|April 9, 2009
Efficacy of citicoline as an acute stroke treatmentWayne M Clark
Stroke|August 27, 2005
Adiponectin: spectator or player?Wayne M Clark
Stroke|August 13, 2011
Intracranial hemorrhage complicating carotid artery stenting and carotid endarterectomyWayne M Clark, Thomas G Brott
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 27, 2008
Keep the three hour TPA window: the lost study of AtlantisWayne M Clark, Kenneth P Madden
Neurology|June 11, 2003
Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety recordMarinos C Dalakas, Wayne M Clark
Nature Reviews. Neurology|August 8, 2012
Stroke: Treatment for acute stroke--the end of the citicoline sagaWayne M Clark, Tegan D Clark
Translational Stroke Research|December 11, 2013
Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic strokeAzita Soltani, Wayne M Clark, Douglas R Hansmann
Neurology|March 23, 2005
Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra)Hall T McGee, Robert A Egan, Wayne M Clark
The Journal of Cardiovascular Nursing|March 31, 2018
The Influence of β-Adrenergic Receptor Kinase-1 on Stroke-induced Immunodeficiency SyndromeAmy Miner Ross, Christopher S Lee, Helmi Lutsep, et al.
Stroke|February 2, 2002
ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic StrokeGregory W Albers, Wayne M Clark, Kenneth P Madden, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|April 9, 2009
Efficacy of citicoline as an acute stroke treatmentWayne M Clark
Stroke|August 27, 2005
Adiponectin: spectator or player?Wayne M Clark
Stroke|August 13, 2011
Intracranial hemorrhage complicating carotid artery stenting and carotid endarterectomyWayne M Clark, Thomas G Brott
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 27, 2008
Keep the three hour TPA window: the lost study of AtlantisWayne M Clark, Kenneth P Madden
Neurology|June 11, 2003
Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety recordMarinos C Dalakas, Wayne M Clark
Nature Reviews. Neurology|August 8, 2012
Stroke: Treatment for acute stroke--the end of the citicoline sagaWayne M Clark, Tegan D Clark
Translational Stroke Research|December 11, 2013
Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic strokeAzita Soltani, Wayne M Clark, Douglas R Hansmann
Neurology|March 23, 2005
Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra)Hall T McGee, Robert A Egan, Wayne M Clark
The Journal of Cardiovascular Nursing|March 31, 2018
The Influence of β-Adrenergic Receptor Kinase-1 on Stroke-induced Immunodeficiency SyndromeAmy Miner Ross, Christopher S Lee, Helmi Lutsep, et al.
Stroke|February 2, 2002
ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic StrokeGregory W Albers, Wayne M Clark, Kenneth P Madden, et al.
Pageof 5